Domestic Animal Endocrinology
Volume 38, Issue 4 , Pages 244-252 , May 2010

Expression of Ki-67, PCNA, and p27kip1 in canine pituitary corticotroph adenomas

  • S.J. van Rijn

      Affiliations

    • Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, Utrecht University, PO Box 80.154, 3508 TD Utrecht, the Netherlands
    • ,
  • G.C.M. Grinwis

      Affiliations

    • Department of Pathobiology, Faculty of Veterinary Medicine, Utrecht University, 3508 TD Utrecht, the Netherlands
    • ,
  • L.C. Penning

      Affiliations

    • Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, Utrecht University, PO Box 80.154, 3508 TD Utrecht, the Netherlands
    • ,
  • B.P. Meij

      Affiliations

    • Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, Utrecht University, PO Box 80.154, 3508 TD Utrecht, the Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 30 2531680; fax: +31 30 2518126.

Received 18 June 2009 ,Revised 18 November 2009 ,Accepted 18 November 2009.

References 

  1. Hanson JM, van’t HM, Voorhout G, Teske E, Kooistra HS, Meij BP. Efficacy of transsphenoidal hypophysectomy in treatment of dogs with pituitary-dependent hyperadrenocorticism. J Vet Intern Med. 2005;19:687–694
  2. Kooistra HS, Voorhout G, Mol JA, Rijnberk A. Correlation between impairment of glucocorticoid feedback and the size of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism. J Endocrinol. 1997;152:387–394
  3. Granger N, de Fornel P, Devauchelle P, Segond S, Delisle F, Rosenberg D. Plasma pro-opiomelanocortin, pro-adrenocorticotropin hormone, and pituitary adenoma size in dogs with cushing's disease. J Vet Intern Med. 2005;19:23–28
  4. Hanson JM, Teske E, Voorhout G, Galac S, Kooistra HS, Meij BP. Prognostic factors for outcome after transsphenoidal hypophysectomy in dogs with pituitary-dependent hyperadrenocorticism. J Neurosurg. 2007;107:830–840
  5. Yeung CM, Chan CB, Leung PS, Cheng CH. Cells of the anterior pituitary. Int J Biochem Cell Biol. 2006;38:1441–1449
  6. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody ki-67. J Immunol. 1984;133:1710–1715
  7. Losa M, Barzaghi RL, Mortini P, Franzin A, Mangili F, Terreni MR, et al. Determination of the proliferation and apoptotic index in adrenocorticotropin-secreting pituitary tumors: Comparison between micro- and macroadenomas. Am J Pathol. 2000;156:245–251
  8. Abe T, Sanno N, Osamura YR, Matsumoto K. Proliferative potential in pituitary adenomas: Measurement by monoclonal antibody mib-1. Acta Neurochir (Wien). 1997;139:613–618
  9. Gejman R, Swearingen B, Hedley-Whyte ET. Role of ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas. Hum Pathol. 2008;39:758–766
  10. Honegger J, Prettin C, Feuerhake F, Petrick M, Schulte-Monting J, Reincke M. Expression of ki-67 antigen in nonfunctioning pituitary adenomas: Correlation with growth velocity and invasiveness. J Neurosurg. 2003;99:674–679
  11. Mastronardi L, Guiducci A, Spera C, Puzzilli F, Liberati F, Maira G. Ki-67 labelling index and invasiveness among anterior pituitary adenomas: Analysis of 103 cases using the mib-1 monoclonal antibody. J Clin Pathol. 1999;52:107–111
  12. Pizarro CB, Oliveira MC, Coutinho LB, Ferreira NP. Measurement of ki-67 antigen in 159 pituitary adenomas using the mib-1 monoclonal antibody. Braz J Med Biol Res. 2004;37:235–243
  13. Thapar K, Kovacs K, Scheithauer BW, Stefaneanu L, Horvath E, Pernicone PJ, et al. Proliferative activity and invasiveness among pituitary adenomas and carcinomas: An analysis using the mib-1 antibody. Neurosurgery. 1996;38:99–106discussion 106–107
  14. Turner HE, Wass JA. Are markers of proliferation valuable in the histological assessment of pituitary tumours?. Pituitary. 1999;1:147–151
  15. Atkin SL, Green VL, Hipkin LJ, Landolt AM, Foy PM, Jeffreys RV, et al. A comparison of proliferation indices in human anterior pituitary adenomas using formalin-fixed tissue and in vitro cell culture. J Neurosurg. 1997;87:85–88
  16. Hsu DW, Hakim F, Biller BMK, de la Monte S, Zervas NT, Klibanski A, et al. Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. J Neurosurg. 1993;78:753–761
  17. Pawlikowski M, Gruszka A, Kurnatowska I, Winczyk K, Kunert-Radek J, Radek A. Proliferating cell nuclear antigen (PCNA) expression in pituitary adenomas: relationship to the endocrine phenotype of adenoma. Folia Histochem Cytobiol. 2006;44:37–41
  18. Bamberger CM, Fehn M, Bamberger AM, Ludecke DK, Beil FU, Saeger W, et al. Reduced expression levels of the cell-cycle inhibitor p27kip1 in human pituitary adenomas. Eur J Endocrinol. 1999;140:250–255
  19. Zhao D, Tomono Y, Nose T. Expression of p27kip1 and ki-67 in pituitary adenomas: An investigation of markers of adenoma invasiveness. Acta Neurochir (Wien). 1999;141:187–192
  20. Sotillo R, Renner O, Dubus P, Ruiz-Cabello J, Martin-Caballero J, Barbacid M, et al. Cooperation between cdk4 and p27kip1 in tumor development: A preclinical model to evaluate cell cycle inhibitors with therapeutic activity. Cancer Res. 2005;65:3846–3852
  21. Dahia PL, Aguiar RC, Honegger J, Fahlbush R, Jordan S, Lowe DG, et al. Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours. Oncogene. 1998;16:69–76
  22. Korbonits M, Chahal HS, Kaltsas G, Jordan S, Urmanova Y, Khalimova Z, et al. Expression of phosphorylated p27(kip1) protein and jun activation domain-binding protein 1 in human pituitary tumors. J Clin Endocrinol Metab. 2002;87:2635–2643
  23. Lidhar K, Korbonits M, Jordan S, Khalimova Z, Kaltsas G, Lu X, et al. Low expression of the cell cycle inhibitor p27kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors. J Clin Endocrinol Metab. 1999;84:3823–3830
  24. Nakabayashi H, Sunada I, Hara M. Immunohistochemical analyses of cell cycle-related proteins, apoptosis, and proliferation in pituitary adenomas. J Histochem Cytochem. 2001;49:1193–1194
  25. Meij BP, Voorhout G, Van den Ingh TS, Hazewinkel HA, Van’t Verlaat JW. Transsphenoidal hypophysectomy in beagle dogs: Evaluation of a microsurgical technique. Vet Surg. 1997;26:295–309
  26. Galac S, Kooistra HS, Teske E, Rijnberk A. Urinary corticoid/creatinine ratios in the differentiation between pituitary-dependent hyperadrenocorticism and hyperadrenocorticism due to adrenocortical tumour in the dog. Vet Q. 1997;19:17–20
  27. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000;182:311–322
  28. Katznelson L, Bogan JS, Trob JR, Schoenfeld DA, Hedley-Whyte ET, Hsu DW, et al. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas. J Clin Endocrinol Metab. 1998;83:1619–1623
  29. Mastronardi L, Guiducci A, Puzzilli F. Lack of correlation between ki-67 labelling index and tumor size of anterior pituitary adenomas. BMC Cancer. 2001;1:12
  30. Kontogeorgos G. Predictive markers of pituitary adenoma behavior. Neuroendocrinology. 2006;83:179–188
  31. Losa M, Franzin A, Mangili F, Terreni MR, Barzaghi R, Veglia F, et al. Proliferation index of nonfunctioning pituitary adenomas: Correlations with clinical characteristics and long-term follow-up results. Neurosurgery. 2000;47:1313–1318discussion 1318–1319
  32. Scheithauer BW, Gaffey TA, Lloyd RV, Sebo TJ, Kovacs KT, Horvath E, et al. Pathobiology of pituitary adenomas and carcinomas. Neurosurgery. 2006;59:341–353discussion 341-353
  33. Yamada S, Ohyama K, Taguchi M, Takeshita A, Morita K, Takano K, et al. A study of the correlation between morphological findings and biological activities in clinically nonfunctioning pituitary adenomas. Neurosurgery. 2007;61:580–584discussion 584–585
  34. van der Vlugt-Meijer RH, Voorhout G, Meij BP. Imaging of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism. Mol Cell Endocrinol. 2002;197:81–87
  35. de Bruin C, Hanson JM, Meij BP, Kooistra HS, Waaijers AM, Uitterlinden P, et al. Expression and functional analysis of dopamine receptor subtype 2 and somatostatin receptor subtypes in canine Cushing's disease. Endocrinology. 2008;149:4357–4366

PII: S0739-7240(09)00146-5

doi: 10.1016/j.domaniend.2009.11.003

Domestic Animal Endocrinology
Volume 38, Issue 4 , Pages 244-252 , May 2010

Article Tools

* Image Usage & Resolution